» Articles » PMID: 5046104

Species Differences in the Biotransformation of a New Antiarrhythmic Agent: Disopyramide Phosphate

Overview
Journal J Pharm Sci
Publisher Elsevier
Specialties Pharmacology
Pharmacy
Date 1972 Jun 1
PMID 5046104
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

In vitro Metabolism of Bumetanide.

Grosa G, Viola F, Caputo O, Biglino G Pharm Res. 2013; 1(6):274-6.

PMID: 24277363 DOI: 10.1023/A:1016302203941.


The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide.

Giacomini K, Swezey S, Blaschke T J Pharmacokinet Biopharm. 1982; 10(1):1-14.

PMID: 7069575 DOI: 10.1007/BF01059180.


Clinical pharmacokinetics of disopyramide.

Karim A, Nissen C, AZARNOFF D J Pharmacokinet Biopharm. 1982; 10(5):465-94.

PMID: 6762414 DOI: 10.1007/BF01059032.


Clinical pharmacokinetics of disopyramide.

Siddoway L, Woosley R Clin Pharmacokinet. 1986; 11(3):214-22.

PMID: 3524956 DOI: 10.2165/00003088-198611030-00003.


Effects of the enantiomers of disopyramide and its major metabolite on the electrophysiological characteristics of the guinea-pig papillary muscle.

Vanhoutte F, Vereecke J, Carmeliet E, Verbeke N Naunyn Schmiedebergs Arch Pharmacol. 1991; 344(6):662-73.

PMID: 1775199 DOI: 10.1007/BF00174750.